One qualifier I brought up before is frequency of dosing. This calculation assumes that those treated get a treatment course every year. That may not be the case, and we don’t have data on the durability as yet. But suppose on average the treatment is applied every second year. That would halve the revenue.
I still like those numbers.
- Forums
- ASX - By Stock
- PAR
- Potential Financial Implications of Yesterday's Results
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.49%
!
44.5¢

Potential Financial Implications of Yesterday's Results, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
44.5¢ |
Change
0.015(3.49%) |
Mkt cap ! $176.8M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 43.0¢ | $364.9K | 828.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 55155 | 43.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.5¢ | 24999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 55155 | 0.435 |
3 | 30187 | 0.430 |
1 | 13793 | 0.425 |
3 | 122128 | 0.420 |
1 | 6531 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.445 | 24999 | 2 |
0.450 | 51992 | 2 |
0.455 | 27000 | 2 |
0.460 | 25000 | 1 |
0.465 | 112360 | 2 |
Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |